IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (including XML style sheet customization and PDF)
Published August 22, 2012 · Recall initiated: July 27, 2012
Summary
FDA records medical device Class II recall Z-2184-2012, published August 22, 2012 and initiated July 27, 2012. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: 280; Lot: Model # L9M2100 - All Software versions of IMPAX CV Reporting. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AGFA Corp.
- Distributor
- Worldwide Distribution - USA (nationwide) and Canada
- Lot
- Model # L9M2100 - All Software versions of IMPAX CV Reporting
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAGFA Digital Radiography X-Ray system DX-D 100 Agfa's DX-D 100 is indicated for use in providing diagnosticJuly 30, 2014
- FDAIMPAX CV Pediatric Echo Reporting, IMPAX CV Echo Measurement Import via Optical Character Recognition (OCR)June 4, 2014
- FDAIMPAX RIS QDOC 5.8February 12, 2014
- FDAIMPAX 5.2 DB Server (running Oracle 10.1.0.4.0), medical imaging Picture Archiving and Communication SystemOctober 30, 2013
- FDABeautyAngel Health Fitness Natural Collagen Stimulation Anti Aging For human use.August 22, 2012
- FDAAlaris Pump Module model 8100. Subsequent product code: FPA The Pump module is intended for facilities thatAugust 22, 2012
Questions about this recall
Was IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (including XML style sheet customization and PDF) recalled?
Yes. FDA published recall Z-2184-2012 on August 22, 2012. Reported hazard: Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report.
What should I do if I have this product?
Voluntary: Firm initiated · Letter